DA Davidson downgraded shares of Nu Skin Enterprises (NYSE:NUS) from a buy rating to a neutral rating in a report published on Wednesday, Benzinga reports. DA Davidson currently has $38.00 price target on the stock, down from their prior price target of $88.00.

Several other analysts also recently weighed in on NUS. Deutsche Bank downgraded Hilton Hotels from a buy rating to a hold rating and set a $92.60 target price for the company. in a research report on Wednesday, May 1st. They noted that the move was a valuation call. Jefferies Financial Group downgraded Keppel REIT from a buy rating to a hold rating in a research report on Wednesday. Stifel Nicolaus set a $99.00 target price on C.H. Robinson Worldwide and gave the stock a hold rating in a research report on Monday, March 25th. ValuEngine upgraded Valmont Industries from a sell rating to a hold rating in a research report on Friday, July 12th. Finally, Zacks Investment Research downgraded Inflarx from a buy rating to a hold rating in a research report on Friday, May 3rd. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $55.63.

Shares of NUS opened at $40.99 on Wednesday. The company has a market capitalization of $2.18 billion, a P/E ratio of 10.24, a PEG ratio of 0.99 and a beta of 0.74. The stock has a fifty day moving average of $47.56. Nu Skin Enterprises has a 52-week low of $35.03 and a 52-week high of $88.68. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.10 and a current ratio of 1.86.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.06. The company had revenue of $623.60 million during the quarter, compared to the consensus estimate of $615.98 million. Nu Skin Enterprises had a return on equity of 26.81% and a net margin of 4.82%. Nu Skin Enterprises’s revenue was up 1.2% on a year-over-year basis. During the same period last year, the company earned $0.79 earnings per share. On average, sell-side analysts anticipate that Nu Skin Enterprises will post 3.56 EPS for the current year.

Several institutional investors have recently made changes to their positions in the company. BlackRock Inc. increased its stake in shares of Nu Skin Enterprises by 19.5% during the first quarter. BlackRock Inc. now owns 7,498,023 shares of the company’s stock valued at $358,856,000 after buying an additional 1,224,725 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Nu Skin Enterprises by 3.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,132,318 shares of the company’s stock valued at $69,442,000 after buying an additional 38,282 shares during the period. Norges Bank purchased a new position in shares of Nu Skin Enterprises during the fourth quarter valued at $56,136,000. Acadian Asset Management LLC increased its stake in shares of Nu Skin Enterprises by 29.5% during the first quarter. Acadian Asset Management LLC now owns 615,706 shares of the company’s stock valued at $29,466,000 after buying an additional 140,367 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Nu Skin Enterprises by 7.3% during the fourth quarter. Geode Capital Management LLC now owns 547,265 shares of the company’s stock valued at $33,563,000 after buying an additional 37,229 shares during the period. Hedge funds and other institutional investors own 77.17% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Article: What does a bar chart mean for investors?

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.